Yakira Capital Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Yakira Capital Management’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,588	Closed	-$323K	–	453
2020 Q4	$323K	Hold	17,588	–	–	0.08%	184
2020 Q3	$323K	Buy	+17,588	New	+$296K	0.1%	155

Yakira Capital Management's CBMG Position: Q1 2021 in Review

Yakira Capital Management sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 17,588 shares — an estimated $323K sold.

Yakira Capital Management first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $323K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Yakira Capital Management reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Yakira Capital Management sold 17,588 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $323K.
Yakira Capital Management first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
Yakira Capital Management's Cellular Biomedicine Group, Inc. position peaked at $323K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Yakira Capital Management's 13F filing for Q1 2021, filed 14 May 2021.